Cognex [CGNX] vs Vontier [VNT] Detailed Stock Comparison
Cognex
NASDAQ
Loading...
Vontier
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Cognex wins in 5 metrics, Vontier wins in 15 metrics, with 0 ties. Vontier appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Cognex | Vontier | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 57.01 | 15.86 | Vontier |
| Price-to-Book Ratio | 4.58 | 5.10 | Cognex |
| Debt-to-Equity Ratio | 5.52 | 177.14 | Cognex |
| PEG Ratio | 42.76 | 13.20 | Vontier |
| EV/EBITDA | 40.84 | 11.24 | Vontier |
| Profit Margin (TTM) | 13.13% | 12.99% | Cognex |
| Operating Margin (TTM) | 17.44% | 17.63% | Vontier |
| EBITDA Margin (TTM) | 17.44% | 17.63% | Vontier |
| Return on Equity | 8.10% | 35.39% | Vontier |
| Return on Assets (TTM) | 4.11% | 8.24% | Vontier |
| Free Cash Flow (TTM) | $134.04M | $344.80M | Vontier |
| Dividend Yield | 0.96% | 0.25% | Cognex |
| 1-Year Return | 6.76% | 21.26% | Vontier |
| Price-to-Sales Ratio (TTM) | 7.41 | 2.01 | Vontier |
| Enterprise Value | $6.72B | $7.83B | Vontier |
| EV/Revenue Ratio | 7.23 | 2.57 | Vontier |
| Gross Profit Margin (TTM) | 67.39% | 47.89% | Cognex |
| Revenue per Share (TTM) | $5 | $20 | Vontier |
| Earnings per Share (Diluted) | $0.72 | $2.63 | Vontier |
| Beta (Stock Volatility) | 1.47 | 1.32 | Vontier |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Cognex vs Vontier Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Cognex | -1.09% | 1.45% | 29.86% | 45.58% | 8.24% | 15.85% |
| Vontier | 0.45% | -2.65% | 6.66% | 18.21% | 5.16% | 11.95% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Cognex | 6.76% | -14.23% | -38.72% | 123.57% | 732.19% | 435.75% |
| Vontier | 21.26% | 67.49% | 19.26% | 19.26% | 19.26% | 19.26% |
Performance & Financial Health Analysis: Cognex vs Vontier
| Metric | CGNX | VNT |
|---|---|---|
| Market Information | ||
| Market Cap | $6.89B | $6.12B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 2,607,209 | 1,213,148 |
| 90 Day Avg. Volume | 2,043,183 | 1,011,629 |
| Last Close | $40.91 | $40.55 |
| 52 Week Range | $22.67 - $44.17 | $27.22 - $42.00 |
| % from 52W High | -7.38% | -3.45% |
| All-Time High | $101.82 (Feb 08, 2021) | $45.62 (Apr 01, 2024) |
| % from All-Time High | -59.82% | -11.11% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | 0.11% |
| Quarterly Earnings Growth | 0.12% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | 0.13% | 0.13% |
| Operating Margin (TTM) | 0.17% | 0.18% |
| Return on Equity (TTM) | 0.08% | 0.35% |
| Debt to Equity (MRQ) | 5.52 | 177.14 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.97 | $8.17 |
| Cash per Share (MRQ) | $1.36 | $2.48 |
| Operating Cash Flow (TTM) | $190.80M | $500.30M |
| Levered Free Cash Flow (TTM) | $166.53M | $353.66M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.96% | 0.25% |
| Last 12-Month Dividend | $0.39 | $0.09 |
Valuation & Enterprise Metrics Analysis: Cognex vs Vontier
| Metric | CGNX | VNT |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 57.01 | 15.86 |
| Forward P/E | 42.76 | 13.20 |
| PEG Ratio | 42.76 | 13.20 |
| Price to Sales (TTM) | 7.41 | 2.01 |
| Price to Book (MRQ) | 4.58 | 5.10 |
| Market Capitalization | ||
| Market Capitalization | $6.89B | $6.12B |
| Enterprise Value | $6.72B | $7.83B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.23 | 2.57 |
| Enterprise to EBITDA | 40.84 | 11.24 |
| Risk & Other Metrics | ||
| Beta | 1.47 | 1.32 |
| Book Value per Share (MRQ) | $8.97 | $8.17 |
Financial Statements Comparison: Cognex vs Vontier
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CGNX | VNT |
|---|---|---|
| Revenue/Sales | $216.04M | $741.10M |
| Cost of Goods Sold | $71.71M | $390.90M |
| Gross Profit | $144.32M | $350.20M |
| Research & Development | $34.73M | $40.20M |
| Operating Income (EBIT) | $26.09M | $130.10M |
| EBITDA | $32.49M | $158.70M |
| Pre-Tax Income | $27.80M | $111.10M |
| Income Tax | $4.20M | $23.20M |
| Net Income (Profit) | $23.60M | $87.90M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CGNX | VNT |
|---|---|---|
| Cash & Equivalents | $143.74M | $333.60M |
| Total Current Assets | $577.68M | $1.37B |
| Total Current Liabilities | $183.96M | $843.10M |
| Long-Term Debt | $63.43M | $2.12B |
| Total Shareholders Equity | $1.45B | $1.11B |
| Retained Earnings | $405.95M | $1.62B |
| Property, Plant & Equipment | $166.19M | $164.90M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CGNX | VNT |
|---|---|---|
| Operating Cash Flow | $47.37M | $110.40M |
| Capital Expenditures | $-2.50M | $-17.70M |
| Free Cash Flow | $38.00M | $92.70M |
| Debt Repayment | N/A | $-133.30M |
| Common Stock Repurchase | $-102.23M | $-55.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CGNX | VNT |
|---|---|---|
| Shares Short | 5.74M | 2.86M |
| Short Ratio | 3.35 | 3.20 |
| Short % of Float | 0.04% | 0.03% |
| Average Daily Volume (10 Day) | 2,607,209 | 1,213,148 |
| Average Daily Volume (90 Day) | 2,043,183 | 1,011,629 |
| Shares Outstanding | 170.43M | 149.30M |
| Float Shares | 160.31M | 145.84M |
| % Held by Insiders | 0.00% | 0.01% |
| % Held by Institutions | 0.99% | 1.04% |
Dividend Analysis & Yield Comparison: Cognex vs Vontier
| Metric | CGNX | VNT |
|---|---|---|
| Last 12-Month Dividend | $0.39 | $0.09 |
| Last 12-Month Dividend Yield | 0.96% | 0.25% |
| 3-Year Avg Annual Dividend | $0.32 | $0.10 |
| 3-Year Avg Dividend Yield | 0.18% | 0.08% |
| 3-Year Total Dividends | $0.95 | $0.30 |
| Ex-Dividend Date | Aug 14, 2025 | Mar 06, 2025 |